1.
Chir Ital
; 46(4): 42-5, 1994.
Artigo
em Italiano
| MEDLINE
| ID: mdl-7882442
RESUMO
Serum thyroglobulin measurement is specified for, the follow-up of patients with treated differentiated thyroid cancer. The thyroglobulin measurement is not good as a screening test of thyroid carcinoma. Serum calcitonin is considered a specific, reliable, easily measurable and repeatable marker of medullary carcinoma, both sporadic and hereditary. This measurement can be used for the follow-up of already diagnosed and treated patients as well as for the screening of medullary carcinoma in patients with thyroid nodules or at risk of MEN 2A and 2B. As there is also evidence of a role for genetic factors in medullary carcinoma when it seems to be sporadic, some recent studies have found genetic markers with the highest diagnostic accuracy.
Assuntos
Biomarcadores Tumorais , Carcinoma Medular/diagnóstico , Marcadores Genéticos , Neoplasias da Glândula Tireoide/diagnóstico , Calcitonina/sangue , Antígeno Carcinoembrionário/análise , Carcinoma Medular/sangue , Carcinoma Medular/terapia , Seguimentos , Humanos , Imuno-Histoquímica , Ensaio Imunorradiométrico , Neoplasia Endócrina Múltipla Tipo 2a/diagnóstico , Mutação , Polimorfismo Genético , Tireoglobulina/sangue , Neoplasias da Glândula Tireoide/sangue , Neoplasias da Glândula Tireoide/terapia , Tireoidectomia , Fatores de Tempo
2.
Minerva Anestesiol
; 46(1): 89-102, 1980 Jan.
Artigo
em Italiano
| MEDLINE
| ID: mdl-6154271
3.
Minerva Anestesiol
; 44(6): 377-90, 1978 Jun.
Artigo
em Italiano
| MEDLINE
| ID: mdl-740248
4.
Minerva Anestesiol
; 42(11): 799-808, 1976 Nov.
Artigo
em Italiano
| MEDLINE
| ID: mdl-1018764
5.
Minerva Anestesiol
; 41(10): 441-4, 1975 Oct.
Artigo
em Italiano
| MEDLINE
| ID: mdl-1230655